Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention and Treatment of Atrial Fibrillation Following Cardiac Surgery

2011 ◽  
Vol 27 (1) ◽  
pp. 91-97 ◽  
Author(s):  
L. Brent Mitchell
Keyword(s):  
Atrial Fibrillation ◽  
Cardiac Surgery ◽  
Canadian Cardiovascular Society ◽  
Prevention And Treatment

Amiodarone Prophylaxis: Impact on Atrial Fibrillation and Outcomes after Cardiac Surgery

2007 ◽  
Vol 42 (8) ◽  
pp. 680-685
Author(s):  
Patricia A. Howard ◽  
Brian J. Barnes
Keyword(s):  
United States ◽  
Atrial Fibrillation ◽  
Cardiovascular Disease ◽  
Cardiac Surgery ◽  
Drug Therapy ◽  
Clinical Outcome ◽  
The United States ◽  
Cardiovascular Pharmacotherapy ◽  
Prevention And Treatment ◽  
Recent Developments

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they keep current with developments in drug therapy.

scholarly journals Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery

2008 ◽  
Vol 51 (8) ◽  
pp. 793-801 ◽  
Author(s):  
Najmeddine Echahidi ◽  
Philippe Pibarot ◽  
Gilles O’Hara ◽  
Patrick Mathieu
Keyword(s):  
Atrial Fibrillation ◽  
Cardiac Surgery ◽  
Prevention And Treatment

Prophylactic Effects of Metoprolol on the Prevention of Atrial Fibrillation after Cardiac Surgery Are Dose Dependent

2014 ◽  
Vol 17 (1) ◽  
pp. 54 ◽  
Author(s):  
Nan Cheng ◽  
Changqing Gao
Keyword(s):  
Atrial Fibrillation ◽  
Cardiac Surgery ◽  
Heart Surgery ◽  
Beta Blockers ◽  
Open Heart Surgery ◽  
Asian Patients ◽  
Different Response ◽  
Prolonged Hospital ◽  
Dose Dependent ◽  
Study Dose

Atrial fibrillation (AF) is one of the most common complications after cardiac surgery. Many studies have reported an incidence of 20%-40% in patients undergoing open heart surgery, and the peak incidence usually occurs between the postoperative days [Fuller 1989; Aranki 1996; Svedjeholm 2000; Maisel 2001]. AF is commonly self-limited and rarely results in postoperative death. However, postoperative AF (POAF) is often associated with complications, including stroke, heart failure, prolonged hospital stay, and increased costs [Maisel 2001; Bramer 2010]. Many pharmacological methods have been used to prevent this complication, and beta-blockers, which have been investigated in several studies, have demonstrated effectiveness [Ali 1997; Connolly 2003; Crystal 2004; Halonen 2006; Imren 2007]. There is currently a consensus in the use of beta-blockers for the prevention of POAF. However, whether the effect of beta-blockers on POAF is dose dependent has not been widely studied [Coleman 2004; Lucio 2004]. In addition, patients with different racial backgrounds have a different response to metoprolol based on body shape. In addition, the CYP2D6 genotypes are different among white and Asian patients. In this study dose-dependent prophylactic effects of beta-blockers, which were obtained in a single center.

Sign in / Sign up

Export Citation Format

Share Document